YourTango

The Generational Reason So Many Women In Their 40s And 50s Are Physically And Spiritually Exhausted

Caught between raising adult children and caring for aging parents, women are exhausted. A therapist shares a few ways to ...
Seeking Alpha

Kalaris Therapeutics: Phase 1a Data De-Risks The Path To 2026 Catalysts

Kalaris Therapeutics offers a differentiated approach to neovascular AMD with its lead candidate TH103, leveraging unique molecular engineering for improved efficacy and durability. KLRS's Phase 1a ...
Seeking Alpha

Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy Transcript

So hi, everyone. Welcome to today's webinar with PPMD, where we're joined by Capricor Therapeutics, who are providing a community update on their Phase 3 trial, HOPE-3, which was evaluating their ...
FierceBiotech

Encoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...
New York Daily News

PATH rolls out TAPP card, phases out MetroCard and SmartLink

The PATH transit system rolled out its new, reloadable TAPP (Total Access PATH Payment) fare card on Thursday as Port Authority moves toward phasing out its antiquated MetroCard and SmartLink systems ...
NJBIZ

New PATH TAPP card debuts as MetroCard phase-out begins

The Port Authority of New York and New Jersey has launched a new reloadable TAPP card for PATH riders. TAPP use has grown dramatically as its been integrated into the system. Nearly 70% of weekday ...
Entrepreneur

Mission vs. Vision — Here’s How Your Success Depends on This Distinction

Crafting clear mission and vision statements is critical to shaping company identity, motivating employees and guiding decision-making. A mission statement defines the current scope and purpose of the ...
New York Post

Port Authority raising PATH fare to $4 — but there’s good news too

The cost of a single PATH train ticket is set to increase next spring — and will climb steadily each year until it hits $4 by 2029, Port Authority officials said. A single trip on the PATH train, ...
MedCity News

Despite Phase 3 Failure, Sarepta Still Sees Path for Muscle Disease Drugs to Secure Full FDA Approval

Two Sarepta Therapeutics drugs for treating different genetic subsets of patients with Duchenne muscular dystrophy failed the confirmatory study required of their accelerated FDA approvals. Sarepta ...
FierceBiotech

BridgeBio aces phase 3 rare disease test, clearing path to FDA

BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA ...
Phys.org

Scientists create a new form of light matter in a quasicrystal

Researchers have for the first time created a reconfigurable polariton 2D quasicrystal. The team from the Skolkovo Institute of Science and Technology (Skoltech), in collaboration with colleagues from ...